subject area of
- Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD Countries. Journal Articles
- Simulating future supply of and requirements for human resources for health in high-income OECD countries Journal Articles
- The effect of patented drug price on the share of new medicines across OECD countries Journal Articles